Aprea Therapeutics
APRE
APRE
66 hedge funds and large institutions have $50.3M invested in Aprea Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
88% less capital invested
Capital invested by funds: $404M → $50.3M (-$354M)
Holders
66
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.99M | |
| 2 | +$1.67M | |
| 3 | +$1.12M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$906K |
| 5 |
Two Sigma Investments
New York
|
+$781K |
Top Sellers
| 1 | -$35.1M | |
| 2 | -$20.5M | |
| 3 | -$12.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.34M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.92M |